MRTC | Malaria Research and Training Center

MRTC - Parasito
Malaria Research and Training Center
The Malaria Research and Training Center (MRTC) of the Faculty of Medicine and Odonto-Stomatology (FMOS) and Faculty of Pharmacy (FAPH) of the University of Sciences, Techniques and Technologies of Bamako (USTTB)
is one of the largest research centers in Africa with excellence in the epidemiology and biology of vectors and parasites of malaria
and other vector-borne diseases such as leishmaniasis, filariasis, arboviruses and tick-borne diseases.
MRTC - Parasito
Malaria Research and Training Center
The MRTC was established in 1992 as a partnership between FMPOS, the National Health Institutes of the United States (NIAID / NIH),
with the support of other partners such as the University of Rome (La Sapienza) the Rockefeller Foundation and the World Health Organization (WHO).
The center has expanded by developing collaborations with several universities and research institutions around the world.
MRTC - Parasito
Malaria Research and Training Center
The MRTC is working with its partners
to develop appropriate methods and strategies for the control of malaria and other vector-borne diseases mentioned above.
The MRTC applies state-of-the-art methods and techniques to study these conditions.
MRTC - Parasito
Malaria Research and Training Center
The MRTC was established in 1992 as a partnership between FMPOS, the National Health Institutes of the United States (NIAID / NIH),
with the support of other partners such as the University of Rome (La Sapienza) the Rockefeller Foundation and the World Health Organization (WHO).
The center has expanded by developing collaborations with several universities and research institutions around the world.
MRTC - Parasito
Malaria Research and Training Center
The MRTC was established in 1992 as a partnership between FMPOS, the National Health Institutes of the United States (NIAID / NIH),
with the support of other partners such as the University of Rome (La Sapienza) the Rockefeller Foundation and the World Health Organization (WHO).
The center has expanded by developing collaborations with several universities and research institutions around the world.
MRTC - Parasito
Malaria Research and Training Center
The MRTC is working with its partners
to develop appropriate methods and strategies for the control of malaria and other vector-borne diseases mentioned above.
The MRTC applies state-of-the-art methods and techniques to study these conditions.
MRTC - Parasito
Malaria Research and Training Center
The MRTC is working with its partners
to develop appropriate methods and strategies for the control of malaria and other vector-borne diseases mentioned above.
The MRTC applies state-of-the-art methods and techniques to study these conditions.

Malaria Research and Training Center (MRTC):

In 1988, the Malaria Research and Training Center was created within the Department of Epidemiology of Parasitic Diseases (DEAP) at the University of Mali, through a partnership grant provided by the Rockefeller Foundation and the World Health Organization to a consortium including the National School of Medicine and Pharmacy (now the Faculty of Medicine, Pharmacy and Odonto-stomatology) in Bamako; the Institute of Parasitology at the University of Rome; and the Laboratory of Parasitic Diseases (LPD) at the U.S. National Institutes of Health.

That partnership grant was renewed in 1993, and additional core funding, including support of an in-country NIAID senior scientist, has been provided by the U.S. Public Health Service’s Office of International Health through its Health and Human Resources in Africa (HHRAA) Initiative, administered by USAID, and by the USAID mission in Bamako. This support has been coordinated by the Laboratory of Parasitic Diseases at NIAID. [...]

Mahamadou Soumana SISSOKO

Biosketch

Deputy Director MRTC - Parasito: Mahamadou Soumana SISSOKO

Level: MD, MSPH, PhD

Research Master: Biostatistics / Clinical Research - Public Health

Holder of a State Doctorate in Medicine (1995) and a University Diploma in Malaria (1998) at the National School of Medicine and Pharmacy, Mali, a Master of Sciences in Public Health (Biostatistics) at Tulane University (Louisiana, United States of America) in 2003 and a PhD degree in Clinical Research - Public Health at Aix-Marseille University, France in 2017, Sissoko is a Master of Research in Public Health.

Deputy Director and Senior Researcher at MRTC - Parasito, he works in clinical research for the development of malaria vaccine candidates and drugs against malaria and other parasitic diseases.

Sissoko teaches Biostatistics, Research Methodology, Epidemiology, Principles of Clinical Trials and the Routine Health Information System (RHIS) at the Faculty of Pharmacy and the Faculty of Medicine and Odonto-Stomatology / University of Sciences, Techniques and Technologies of Bamako, Mali.

He is the author of 37 scientific publications.

The Developing Excellence in Leadership and Genetics Training for Malaria Elimination in sub-Saharan Africa (DELGEME) is a training programme sponsored by the Wellcome Trust Developing Excellence in Leadership, Training and Science Africa (DELTAS Africa) initiative in partnership with the Department of International Development (DFID) and the Alliance for Accelerating Excellence in Science in Africa (AESA).

Please click on the link below to see www.delgeme.org

DELGEME Read more

WANECAM is the West African Network for Clinical Trials of Antimalarial drugs. This network is being supported by grants from the European & Developing Countries Clinical Trials Partnership (EDCTP).

The WANECAM 2 project aims to accelerate the development of the Ganaplacide/lumefantrine combination for the treatment of uncomplicated malaria by conducting clinical trials in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and Niger.

WANECAM Read more

Malaria in pregnant is a public health problem in sub Saharan countries where 11 million pregnancies are exposed to malaria infection. Plasmodium falciparum in pregnant can cause adverse maternal health and poor birth outcomes. Artemisin-based Combination Therapy (ACT) used in treatment of uncomplicated Plasmodium falciparum malaria in pregnant women has the efficacy in Africa.

PYRAPREG Read more

The PfTBV Malaria Blocking Transmission Consortium was formed in 2019 to develop and execute on a strategy to compare, select and develop malaria vaccine candidates. Using innovative trial designs, the consortium will 1) accelerate well-established candidates into the clinic for direct comparison and evaluation 2) select the most efficacious malaria vaccine to stop transmission of Plasmodium falciparum (Pf) from humans to mosquitoes, and 3) establish assays, endpoints, and regulatory pathways for definitive efficacy assessment of a transmission blocking vaccine (TBV).

PfTBV-Consortium Read more